SciClone Pharmaceuticals
SciClone Pharmaceuticals is a specialty pharmaceutical company that focuses on developing and marketing therapies for oncology, infectious diseases, and cardiovascular disorders, primarily in China, the United States, and Hong Kong. Its lead product, ZADAXIN, is utilized for the treatment of hepatitis B and C, certain cancers, and as an immune system enhancer, with ongoing development for sepsis treatment. The company also offers a range of other products, including DC Bead, an approved treatment for liver cancer, and ondansetron RapidFilm, which addresses chemotherapy-induced nausea and vomiting. SciClone markets these products through various distribution channels and has established partnerships to promote specific therapies like Angiomax and Cleviprex. Founded in 1989 and headquartered in Foster City, California, SciClone remains committed to addressing unmet medical needs in rapidly growing therapeutic areas.
Ability Pharmaceuticals is a drug discovery and development company based in Barcelona, Spain. It develops human therapeutics targeting cell membranes to treat cancer and other indications with unmet medical needs. Ability Pharmaceuticals is focused on developing new drugs for the treatment of lung cancer and pancreatic cancer. The company develops Lipid Analogue Therapeutics, a new drug class that modifies the composition of the cell membrane and displays a capacity to influence the local organization of lipid structures in the cell membrane, inducing the formation of non-lamellar phase structures. Its development pipeline includes ABTL0812 product in preclinical development; and ABTL1014, a drug candidate in preclinical characterization.
NovaMed Pharmaceuticals (诺凡麦医药) is a Chinese group based on virtual integration. It is focused on complete business functions such as sales and marketing, register, circulation, manufacture, and R&D. NovaMed Pharmaceuticals was founded by senior management personnel in transnational pharmaceutical companies. The founders are professionals with broad social networks and domestic market knowledge.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.